These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 33045386)

  • 21. Antibiotic Stewardship and Inpatient Clostridioides difficile Testing in Solid Organ Transplant Recipients: The Need for Multilevel Checks and Balances.
    Kueht M; Kharsa A; Mujtaba M; Kulkarni R; Britt R; Lea AS; Hafiz G; Fair J; Reynoso D
    Transplant Proc; 2022 Apr; 54(3):605-609. PubMed ID: 35249732
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Improving Appropriate Diagnosis of
    Liu C; Lan K; Krantz EM; Kim HN; Zier J; Bryson-Cahn C; Chan JD; Jain R; Lynch JB; Pergam SA; Pottinger PS; Sweet A; Whimbey E; Bryan A
    Open Forum Infect Dis; 2020 Oct; 7(10):ofaa366. PubMed ID: 33094113
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Colonization with Gastrointestinal Pathogens Prior to Hematopoietic Cell Transplantation and Associated Clinical Implications.
    Kubiak J; Davidson E; Soave R; Kodiyanplakkal RP; Robertson A; Besien KV; Shore TB; Lee JR; Westblade LF; Satlin MJ
    Transplant Cell Ther; 2021 Jun; 27(6):499.e1-499.e6. PubMed ID: 33811020
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Patient Outcomes With Prevented vs Negative
    Madden GR; Enfield KB; Sifri CD
    Open Forum Infect Dis; 2020 Apr; 7(4):ofaa094. PubMed ID: 32328506
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Implementation of the Targeted Assessment for Prevention Strategy in a healthcare system to reduce
    White KA; Soe MM; Osborn A; Walling C; Fike LV; Gould CV; Kuhar DT; Edwards JR; Cochran RL
    Infect Control Hosp Epidemiol; 2020 Mar; 41(3):295-301. PubMed ID: 31928537
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clostridioides difficile Infection in the Stem Cell Transplant and Hematologic Malignancy Population.
    Misch EA; Safdar N
    Infect Dis Clin North Am; 2019 Jun; 33(2):447-466. PubMed ID: 31005136
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High Prevalence of Multidrug-Resistant
    Mutai WC; Mureithi MW; Anzala O; Revathi G; Kullin B; Burugu M; Kyany'a C; Odoyo E; Otieno P; Musila L
    Front Cell Infect Microbiol; 2020; 10():604986. PubMed ID: 33628744
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Significance of a positive Clostridium difficile toxin test after hematopoietic stem cell transplantation.
    Akahoshi Y; Kimura S; Nakano H; Harada N; Kameda K; Ugai T; Wada H; Yamasaki R; Ishihara Y; Kawamura K; Sakamoto K; Ashizawa M; Sato M; Terasako-Saito K; Nakasone H; Kikuchi M; Yamazaki R; Kanda J; Kako S; Nishida J; Kanda Y
    Clin Transplant; 2016 Jun; 30(6):703-8. PubMed ID: 27019071
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Review of high dose vancomycin in the treatment of
    Bader MS; Hawboldt J; Main C; Mertz D; Loeb M; Farrell A; Joyce J
    Infect Dis (Lond); 2020; 52(12):847-857. PubMed ID: 32744879
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of the National Healthcare Safety Network standardized infection ratio risk adjustment for healthcare-facility-onset
    Polage CR; Quan KA; Madey K; Myers FE; Wightman DA; Krishna S; Grein JD; Gibbs L; Yokoe D; Mabalot SC; Chinn R; Hallmark A; Rubin Z; Fontenot M; Cohen S; Birnbaum D; Huang SS; Torriani FJ
    Infect Control Hosp Epidemiol; 2020 Apr; 41(4):404-410. PubMed ID: 32052726
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clostridium difficile infection after allogeneic hematopoietic stem cell transplantation: incidence, risk factors, and outcome.
    Willems L; Porcher R; Lafaurie M; Casin I; Robin M; Xhaard A; Andreoli AL; Rodriguez-Otero P; Dhedin N; Socié G; Ribaud P; Peffault de Latour R
    Biol Blood Marrow Transplant; 2012 Aug; 18(8):1295-301. PubMed ID: 22387347
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recommendations for the diagnosis and treatment of Clostridioides difficile infection: An official clinical practice guideline of the Spanish Society of Chemotherapy (SEQ), Spanish Society of Internal Medicine (SEMI) and the working group of Postoperative Infection of the Spanish Society of Anesthesia and Reanimation (SEDAR).
    Bouza E; Aguado JM; Alcalá L; Almirante B; Alonso-Fernández P; Borges M; Cobo J; Guardiola J; Horcajada JP; Maseda E; Mensa J; Merchante N; Muñoz P; Pérez Sáenz JL; Pujol M; Reigadas E; Salavert M; Barberán J
    Rev Esp Quimioter; 2020 Apr; 33(2):151-175. PubMed ID: 32080996
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risk factors for development of initial Clostridioides difficile infection.
    Wagner JL; Stover KR; Bell AM; Barber KE
    J Glob Antimicrob Resist; 2021 Jun; 25():18-22. PubMed ID: 33667706
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Uncovering the Harms of Treating Clostridioides difficile Colonization.
    Polage CR; Turner NA
    mSphere; 2021 Jan; 6(1):. PubMed ID: 33441413
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of Clostridioides difficile Infection and Non-compliance with Treatment Guidelines in Adults in 10 US Geographical Locations, 2013-2015.
    Novosad SA; Mu Y; Winston LG; Johnston H; Basiliere E; Olson DM; Farley MM; Revis A; Wilson L; Perlmutter R; Holzbauer SM; Whitten T; Phipps EC; Dumyati GK; Beldavs ZG; Ocampo VLS; Davis CM; Kainer M; Gerding DN; Guh AY
    J Gen Intern Med; 2020 Feb; 35(2):412-419. PubMed ID: 31768906
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diagnosis and treatment of Clostridioides difficile infection.
    Mateu L; Fernández-Rivas G; Sopena N
    Med Clin (Barc); 2020 Jul; 155(1):30-35. PubMed ID: 32430207
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Safety and Efficacy of Fidaxomicin and Vancomycin in Children and Adolescents with Clostridioides (Clostridium) difficile Infection: A Phase 3, Multicenter, Randomized, Single-blind Clinical Trial (SUNSHINE).
    Wolf J; Kalocsai K; Fortuny C; Lazar S; Bosis S; Korczowski B; Petit A; Bradford D; Croos-Dabrera R; Incera E; Melis J; van Maanen R
    Clin Infect Dis; 2020 Dec; 71(10):2581-2588. PubMed ID: 31773143
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of an electronic hard-stop clinical decision support tool to limit repeat
    Kwon JH; Reske KA; Hink T; Jackups R; Burnham CD; Dubberke ER
    Infect Control Hosp Epidemiol; 2019 Dec; 40(12):1423-1426. PubMed ID: 31647044
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ultrasensitive Clostridioides difficile Toxin Testing for Higher Diagnostic Accuracy.
    Sandlund J; Davies K; Wilcox MH
    J Clin Microbiol; 2020 May; 58(6):. PubMed ID: 32269098
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antimicrobial resistance surveillance of Clostridioides difficile in Australia, 2015-18.
    Putsathit P; Hong S; George N; Hemphill C; Huntington PG; Korman TM; Kotsanas D; Lahra M; McDougall R; McGlinchey A; Moore CV; Nimmo GR; Prendergast L; Robson J; Waring L; Wehrhahn MC; Weldhagen GF; Wilson RM; Riley TV; Knight DR
    J Antimicrob Chemother; 2021 Jun; 76(7):1815-1821. PubMed ID: 33895826
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.